Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Statement on FDA's Proposed National Standards for Licensure of Distributors and 3PLs
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s (FDA) proposed national licensure standards for distributors and third-party logistics providers (3PLs). HDA recently submitted public comments to FDA on the agency’s proposed standards, which are required to be established under the 2013 Drug Supply Chain Security Act (DSCSA).
AmerisourceBergen and the Role of Local Philanthropy During COVID-19
As the logistics experts of healthcare, distributors’ daily mission during the COVID-19 pandemic is to support a safe, efficient and resilient supply chain. Accordingly, distributors are working with partners inside and outside the healthcare community to support hospitals, pharmacies and healthcare providers.
HDA Research Foundation Announces the 2023 Karen J. Ribler Supply Chain Scholars
The HDA Research Foundation announced four recipients of the Karen J. Ribler Scholarship at its Fifteenth Annual CEO Roundtable Fundraiser in Washington, D.C.
HDA’s 2026 Healthcare Outlook Highlights the Industry’s Policy Priorities
Chain Drug Review, a pharmacy trade publication, published its annual “Healthcare Outlook” column by HDA President and CEO Chip Davis, which examines the industry’s priorities for 2026.
Strengthening the Strategic National Stockpile for the Future
The Strategic National Stockpile (SNS) plays a critical role in supplementing state and local supplies during public health emergencies. The lifesaving medicines and healthcare products secured by the stockpile serve as a buffer when supplies may otherwise not be immediately available.